Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
8.22
-0.33 (-3.86%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Employees
Kyntra Bio had 34 employees as of December 31, 2025. The number of employees decreased by 191 or -84.89% compared to the previous year.
Employees
34
Change (1Y)
-191
Growth (1Y)
-84.89%
Revenue / Employee
$135,765
Profits / Employee
$5,388,000
Market Cap
33.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -191 | -84.89% |
| Dec 31, 2024 | 225 | -261 | -53.70% |
| Dec 31, 2023 | 486 | -106 | -17.91% |
| Dec 31, 2022 | 592 | 26 | 4.59% |
| Dec 31, 2021 | 566 | -33 | -5.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| NextCure | 40 |
| Quince Therapeutics | 38 |
| Actinium Pharmaceuticals | 27 |
| BriaCell Therapeutics | 16 |
| Context Therapeutics | 15 |
| CervoMed | 15 |
| Barinthus Biotherapeutics | 14 |
KYNB News
- 7 days ago - Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 8 days ago - Kyntra Bio cuts max royalty cap to $65M from $125M, pays $42.6M upfront - TheFly
- 8 days ago - Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation - GlobeNewsWire
- 23 days ago - Kyntra Bio reports Q2 EPS $2.96, consensus ($3.18) - TheFly
- 26 days ago - Kyntra Bio Earnings Call Transcript: Q2 2026 - Transcripts
- 26 days ago - Kyntra Bio Earnings release: Q2 2026 - Filings
- 26 days ago - Kyntra Bio Quarterly report: Q2 2026 - Filings
- 26 days ago - Kyntra Bio Slides: Q2 2026 - Filings